Cargando…
In silico screening of antiviral compounds from Moringa oleifera for inhibition of SARS-CoV-2 main protease
COVID-19 as per early April 2021, has globally exceeded 129 million cases and is the cause of about 2.8 million deaths. Since the illness is known to have a wide array of symptoms, in addition to its ability to spread rapidly through contact and the complexity involved in developing drugs, there is...
Autores principales: | Sivani, Bala Mohan, Venkatesh, Priyanka, Murthy, T.P.Krishna, Kumar, S.Birendra |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Authors. Published by Elsevier B.V.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8547798/ http://dx.doi.org/10.1016/j.crgsc.2021.100202 |
Ejemplares similares
-
Phytochemistry and Pharmacology of Moringa oleifera Lam
por: Paikra, Birendra Kumar, et al.
Publicado: (2017) -
In silico analysis of Phyllanthus amarus phytochemicals as potent drugs against SARS-CoV-2 main protease
por: Murthy, T.P. Krishna, et al.
Publicado: (2021) -
Extraction, purification, and activity of protease from the leaves of
Moringa oleifera
por: Banik, Swarnali, et al.
Publicado: (2018) -
Phytochemical Analysis, Antimutagenic and Antiviral Activity of Moringa oleifera L. Leaf Infusion: In Vitro and In Silico Studies
por: Rahayu, Ika, et al.
Publicado: (2022) -
In-silico elucidation of Moringa oleifera phytochemicals against diabetes mellitus
por: Zainab, Bibi, et al.
Publicado: (2020)